The Food and Drug Administration (FDA) examined Vidalia Sweet Produce in Cobbtown on Feb. 24 for foodborne biological risks, based on data available from the FDA’s website.
The inspection’s final findings concluded that Vidalia Sweet Produce was not required to make adjustments to its management operations.
The FDA regularly inspects facilities nationwide to verify that workplaces and their products adhere to regulations enacted to protect public health. Outcomes from these inspections are published.
According to information on its site, the FDA is a federal agency with primary oversight of the safety and quality of human and animal drugs, biological products, medical goods and tobacco items throughout their production and distribution.
Details for this article were provided by the U.S. Food and Drug Administration. You can access the underlying source data here.
